BCV
BNTX icon

Banque Cantonale Vaudoise’s BioNTech BNTX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
4,500
+642
+17% +$60.4K 0.06% 130
2026
Q1 		$343K Buy
3,858
+3,594
+1,361% +$369K 0.01% 556
2025
Q4 		$25K Sell
264
-100
-27% -$10.1K ﹤0.01% 764
2025
Q3 		$36K Sell
364
-26
-7% -$2.78K ﹤0.01% 727
2025
Q2 		$42K Hold
390
– – ﹤0.01% 663
2025
Q1 		$36K Buy
+390
New +$43.7K ﹤0.01% 713
2024
Q3 		$38K Sell
323
-2,151
-87% -$198K ﹤0.01% 650
2024
Q2 		$199K Hold
2,474
– – 0.01% 598
2024
Q1 		$229K Sell
2,474
-60
-2% -$5.75K 0.01% 553
2023
Q4 		$266K Hold
2,534
– – 0.01% 531
2023
Q3 		$273K Sell
2,534
-31
-1% -$3.43K 0.01% 600
2023
Q2 		$277K Sell
2,565
-229
-8% -$25.8K 0.01% 637
2023
Q1 		$347K Buy
2,794
+681
+32% +$93.5K 0.02% 552
2022
Q4 		$320K Sell
2,113
-12,100
-85% -$1.86M 0.02% 573
2022
Q3 		$1.92M Buy
14,213
+606
+4% +$92.6K 0.11% 178
2022
Q2 		$2.03M Buy
13,607
+6,902
+103% +$1.05M 0.11% 182
2022
Q1 		$1.15M Sell
6,705
-5,537
-45% -$930K 0.05% 356
2021
Q4 		$3.15M Buy
12,242
+1,557
+15% +$426K 0.12% 157
2021
Q3 		$2.92M Sell
10,685
-365
-3% -$116K 0.13% 162
2021
Q2 		$2.47M Buy
11,050
+10,000
+952% +$1.89M 0.11% 192
2021
Q1 		$114K Buy
+1,050
New +$112K 0.01% 892
2020
Q3 		– Sell
-370
Closed -$25K – 1056
2020
Q2 		$25K Buy
+370
New +$18.5K ﹤0.01% 855

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Banque Cantonale Vaudoise's BNTX Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its BioNTech (BNTX) stake by 17% in Q2 2026, buying an estimated $60.4K and bringing the position to 4,500 shares worth $419K. The position accounts for 0.06% of the portfolio, ranked #130.

Banque Cantonale Vaudoise first reported a position in BNTX in Q2 2020 and has held it in 22 quarters since. The position peaked at $3.15M in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Banque Cantonale Vaudoise held 4,500 shares of BioNTech worth $419K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 642 BioNTech shares in Q2 2026, an estimated $60.4K.
  • BioNTech made up 0.06% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #130 holding.
  • Banque Cantonale Vaudoise first reported a position in BioNTech in Q2 2020 and has held it in 22 quarters since.
  • Banque Cantonale Vaudoise's BioNTech position peaked at $3.15M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.